Piramal Enterprises Limited (PEL, NSE: PEL, BSE: 500302) gab heute bekannt, dass seine hundertprozentige Tochtergesellschaft in den USA eine...
Piramal Enterprises conclut un accord pour l'acquisition d'Ash Stevens Inc., un organisme de développement et de fabrication en...
Piramal Enterprises Limited (PEL, NSE: PEL, BSE: 500302) announced today that its wholly owned subsidiary in the US has entered into an...
Piramal Pharma Solutions, fournisseur de services de fabrication et de développement de produits médicamenteux stériles, a annoncé des...
Piramal Pharma Solutions, ein Anbieter von sterilen Produktentwicklungs- und Produktionsdiensten, hat Pläne für einen 25 Millionen US-Dollar...
Piramal Pharma Solutions, un fornitore di servizi per lo sviluppo e la produzione di prodotti farmaceutici sterili, ha annunciato che...
Piramal Pharma Solutions, a provider of sterile drug product development and manufacturing services, has announced plans for a $25 million...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.